(Q38006731)

English

LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos

scientific article published on April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

1

object named as

Lina Badimon

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

author name string

Gemma Vilahur

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1254

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

18-32

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Conditional risk factors for atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Implications of emerging risk factors for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Cell biology and lipoproteins in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

LDL receptor-related protein and the vascular wall: implications for atherothrombosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

LRP: role in vascular wall integrity and protection from atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Adipocyte differentiation-related protein is induced by LRP1-mediated aggregated LDL internalization in human vascular smooth muscle cells and macrophages.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Oxidized LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Inhibitory effects of N-acetylcysteine on scavenger receptor class A expression in human macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Macrophage scavenger receptor (SR-A I/II) deficiency reduced diet-induced atherosclerosis in C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Role of smooth muscle cells in the initiation and early progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Low-density lipoproteins induce heat shock protein 27 dephosphorylation, oligomerization, and subcellular relocalization in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Plaque progression and regression in atherothrombosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Scavenger receptor BI and cholesterol trafficking

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

HDL cholesterol and protective factors in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Platelet activation by low density lipoprotein and high density lipoprotein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Emerging role of high density lipoproteins as a player in the immune system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06480.X

21 January 2018

Identifiers

10.1111/J.1749-6632.2012.06480.X

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38006731&oldid=2080407018"